SPARK, studying pathways of resistance in KRAS-driven cancers
May 31, 2023 https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.TPS3166
SPARK, studying pathways of resistance in KRAS-driven cancers
Creating an Advocacy Group at the Onset of a Global Pandemic: KRAS Kickers Founder Shares Her Story
Getting Stage 3 Lung Cancer for Christmas Only Made Me Love the Holidays More
FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC
Cancer drugs are closing in on some of the deadliest mutations
SPARK – A STUDY FOR PATIENTS WITH KRAS DRUG RESISTANCE
KRAS Kickers Give Cancer the Boot!
LCRF and KRAS Kickers Announce Partnership
Hug from Brenda
Need a hug?
SPARK, studying pathways of resistance in KRAS-driven cancers